Suppr超能文献

肾动脉介入治疗中使用的导管和器械设计的技术进步:对并发症的影响。

Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications.

作者信息

Zeller Thomas, Frank Ulrich, Müller Christian, Bürgelin Karlheinz, Schwarzwälder Uwe, Sinn Lutz, Horn Barbara, Roskamm Helmut, Neumann Franz-Josef

机构信息

Department of Angiology, Herz-Zentrum Bad Krozingen, Germany.

出版信息

J Endovasc Ther. 2003 Oct;10(5):1006-14. doi: 10.1177/152660280301000526.

Abstract

PURPOSE

To analyze the impact of technical improvements in stent devices and guiding catheters (e.g., reduced device diameter, increased flexibility) on the complication rates associated with percutaneous renal artery interventions.

METHODS

During a 5-year period (1997-2001), 268 consecutive patients (178 men; mean age 67+/-9 years) had 370 atherosclerotic renal artery stenoses (RAS) > or =70% treated with angioplasty/stenting in 320 procedures. The guiding catheter technique was used routinely until 2000; in 2001, a guiding sheath was used in 29% of cases. From 1997 to 2000, sealing devices were frequently used for sheath removal; during the last year, the sheaths were removed using the Femostop device.

RESULTS

In 320 interventions, 32 (10%) complications occurred, with a decreasing frequency during the last 2 years (1996/97: 13% [7/53]; 1998: 16% [9/57]; 1999: 15% [11/74]; 2000: 4% [3/70]; 2001: 3% [2/66]). There were 21 (6.6%) local complications, including 4 cases requiring permanent hemodialysis after the intervention and 11 (3.4%) access site complications. No procedure-related death occurred. During the study period, the average sheath diameter was reduced from 8.15+/-0.76 F to 6.15+/-0.63 F (p<0.05). Mean procedural time was reduced from 42+/-13 minutes to 23+/-11 minutes (p<0.05). The initial heparin dose was reduced from 10,000 to 5000 units.

CONCLUSIONS

In parallel with the use of more flexible catheters and premounted stents of lower profile, the complication rate of renal angioplasty/stenting of atherosclerotic RAS has been reduced significantly during a 5-year period.

摘要

目的

分析支架装置和引导导管的技术改进(如减小装置直径、增加柔韧性)对经皮肾动脉介入治疗相关并发症发生率的影响。

方法

在5年期间(1997 - 2001年),268例连续患者(178例男性;平均年龄67±9岁)在320例手术中对370处≥70%的动脉粥样硬化性肾动脉狭窄(RAS)进行了血管成形术/支架置入术治疗。直到2000年常规使用引导导管技术;2001年,29%的病例使用了引导鞘。1997年至2000年期间,经常使用密封装置拔除鞘管;在最后一年,使用Femostop装置拔除鞘管。

结果

在320例介入治疗中,发生了32例(10%)并发症,在最后2年发生率降低(1996/97年:13% [7/53];1998年:16% [9/57];1999年:15% [11/74];2000年:4% [3/70];2001年:3% [2/66])。有21例(6.6%)局部并发症,包括4例介入治疗后需要永久性血液透析的病例和11例(3.4%)穿刺部位并发症。未发生与手术相关的死亡。在研究期间,鞘管的平均直径从8.15±0.76F减小到6.15±0.63F(p<0.05)。平均手术时间从42±13分钟减少到23±11分钟(p<0.05)。初始肝素剂量从10000单位减少到5000单位。

结论

在5年期间,随着使用更柔韧的导管和低轮廓的预装支架,动脉粥样硬化性RAS的肾血管成形术/支架置入术的并发症发生率显著降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验